Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2

American Journal of Kidney Diseases

Volumn 37, Issue 6, 2001, Pages 1120-1130

  West, Clark D ^a   Witte, David P ^a   McAdams, A James ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

C3; Glomerular deposits; Hypocomplementemia; Membranoproliferative glomerulonephritis (MPGN) type 2; Nephritic factor (NF)

Indexed keywords

COMPLEMENT COMPONENT C3; NEPHRITIC FACTOR; PROPERDIN;

ALLERGIC GLOMERULONEPHRITIS; ANTIBODY LABELING; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN DETERMINATION;

EID: 0035009657     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.24511     Document Type: Article

References (45)

1. Heterogenity of NF and its identification as an immunoglobulin
2. Further evidence for the antibody nature of C3 NF (C3NeF)
3. The complement abnormalities of lipodystrophy
4. NFs predispose to chronic glomerulonephritis
5. An inherited defect in the C3 convertase, C3b,Bb, associated with glomerulonephritis
6. Hypocomplementemic glomerulonephritis in an infant and mother. Evidence for an abnormal form of C3
7. Activation of the alternative pathway of complement by monoclonal γ light chains in membranoproliferative glomerulonephritis
8. Paramesangial glomerular deposits in membranoproliferative glomerulonephritis type 2 correlate with hypocomplementemia
9. The alternative pathway C3 convertase and glomerular deposits
10. Glomerular paramesangial deposits: Association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III
11. Observations on the evolution of idiopathic rapidly progressive glomerulonephritis
12. Acute non-proliferative glomerulitis: A cause of renal failure unique to children
13. Glomerular deposits and hypoalbuminemia in acute poststreptococcal glomerulonephritis
14. Texas Red, a hydrophilic, red-emitting fluorophore for use with fluorescein in dual parameter flow, microfluorometric and fluorescein microscopic studies
15. The alternative pathway of complement
16. Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3
17. The covalent binding reaction of C3 and C4
18. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes
19. Generation of three different fragments of bound C3 with purified factor I or serum. 1. Requirements for factor H versus CR1 co-factor activity
20. The chemistry and biology of C3, C4, and C5
21. The incorporation of C3 NF (C3NeF) into a stabilized C3 convertase, C3b,Bb, and its release after decay of convertase function
22. 1H
23. Antinuclear factors and serum complement in systemic lupus erythematosus
24. 1C globulin in hypocomplementemic glomerulonephritis
25. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis
26. 2D), and C3g
27. Dense deposit disease: A variant of membranoproliferative glomerulonephritis
28. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products
29. Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia
30. Studies on chronic membranoproliferative glomerulonephritis with hypocomplementemia
31. IgA nephropathy
32. Membranoproliferative glomerulonephritis type III: Association of glomerular deposits with circulating NF-stabilized convertase
33. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III
34. Two types of C3 NeF: Properdin dependent C3NeF and properdin independent C3NeF
35. The effect of NF on C3 and on the terminal pathway of complement in vivo and in vitro
36. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis
37. The prognostic value of some clinical and histological parameters in membranoproliferative glomerulonephritis
38. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children
39. Mesangiocapillary glomerulonephritis type 2 (dense deposit disease): Clinical features of progressive disease
40. Characteristics of a benign subtype of dense deposit disease: Comparison with the progressive form of this disease
41. Dense intramembranous deposit disease: A clinical comparison of histological subtypes
42. Alteration of C3 NF in a patient with membranoproliferative glomerulonephritis type 2
43. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes
44. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley and York blood group antisera